Advent International partners with luxury fashion brand ZIMMERMANN to support continued global growth

Sydney, Paris, 8 August 2023 – Advent International (“Advent”), one of the world’s largest and most experienced private equity investors, today announces that it has reached an agreement to acquire a majority shareholding in ZIMMERMANN, the luxury fashion brand.

Founded by sisters Nicky and Simone Zimmermann and headquartered in Sydney, Australia, ZIMMERMANN has grown into a globally recognised iconic luxury fashion brand.

Under the terms of the acquisition, Advent will acquire a majority shareholding in ZIMMERMANN from Style Capital, who together with the Zimmermann family, will retain a significant minority shareholding. The founders and the ZIMMERMANN management team will continue to drive the brand’s future growth.

The investment from Advent will enable ZIMMERMANN to build on its strong multi-decade performance, by accelerating the brand’s international expansion in existing and new key luxury markets, such as Asia and the Middle East, to further grow its product categories and accessories, and strengthen its online and omni-channel presence. Advent will leverage its considerable experience within the consumer sector – which includes the recently signed investment in Parfums de Marly and INITIO Parfums Privés, as well as investments in Douglas (specialist retailer of premium beauty products, including perfumes), Orveon (owner of the bareMinerals, BUXOM, and Laura Mercier cosmetics brands), and lululemon athletica (premier specialty retailer of athletic and yoga apparel).

Commenting on the announcement, Ranjan Sen, Managing Partner at Advent International, said, “ZIMMERMANN presents a rare and exciting opportunity to acquire a fast-growing iconic luxury fashion brand with significant potential for further expansion. The ZIMMERMANN team have successfully created a distinctive and desirable global luxury brand, which has built a loyal customer base around the world. We look forward to supporting the management team around the CEO, Chris Olliver, and Nicky and Simone Zimmermann, to help build on the company’s strong foundations and deliver superior continuous growth.”

Chris Olliver, CEO of ZIMMERMANN, added, “We welcome Advent as a successful global and like-minded investor. They bring proven experience supporting luxury brands in taking this next step and we are thrilled by the opportunity to work together.”

Nicky Zimmermann, Chief Creative Officer and co-founder, said, “We are really excited to partner with the teams at Advent and Style Capital as we continue on our journey to build a unique global luxury brand from Australia. There are so many exciting opportunities for ZIMMERMANN ahead and Simone and I feel extremely fortunate to be going on this journey with our team, one that started nearly 30 years ago at Paddington Markets in Sydney. For us, the opportunity to work alongside so many talented and passionate people each day is a privilege and there is so much we want to achieve together. We look forward to working collaboratively with our new partners to achieve our shared ambitions for the brand, with our loyal clients at the centre of that vision.”

Roberta Benaglia, CEO of Style Capital, added, “We are delighted to partner with Advent and to continue to support the ZIMMERMANN team. Early in our conversations with the Advent team, it became clear that they recognised the considerable potential within the brand and shared a common vision for further expansion over the long-term.”

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 410 private equity investments across 42 countries, and as of March 31, 2023, had $95 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website:
www.adventinternational.com
LinkedIn:
www.linkedin.com/company/advent-international

About Style Capital

Style Capital is an Italian private equity firm, with a focus on fashion and luxury industry, providing not only capital but also a business and strategic support to the portfolio companies.

Style Capital combines its sector expertise with a deep knowledge of European and Asian markets, supporting the growth of companies operating in the global market, whose distinguishing features are creativity, product quality and inimitability, selective distribution and innovation.

Due to its specific skills, in-deep knowledge of the target industries and a solid and outstanding track record, Style Capital aims to be the perfect shareholder for supporting the growth of the portfolio’s companies.

The following investments are part of the Style Capital track record: Twin-Set, Sundek, Golden Goose, forte_forte, MSGM, Re/Done and LUISAVIAROMA.

About ZIMMERMANN

One glance and you know that dress or swimsuit is ZIMMERMANN. This iconic Australian luxury brand stays true to its original vision: sophisticated femininity, a passion for detail and a love of colour and print.

Sisters Nicky and Simone Zimmermann founded their namesake label in 1991. Early in its evolution, ZIMMERMANN took the bold step of fusing fashion with swimwear and presented it to the world. It immediately found its following with the fashion elite, creating a new point of reference in flattering, feminine and stylish resort wear.

The ZIMMERMANN collections have come to represent so much more than the original swimsuit with a complete wardrobe offering for the sophisticated, global, ZIMMERMANN woman.

ZIMMERMANN maintains a collection of 58 standalone stores across Australia, the USA, UK, Europe and China that reflect the brand’s modern and optimistic aesthetic. In the digital world, ZIMMERMANN has created a successful and dynamic online platform, ZIMMERMANN.COM. The brand also maintains a selective presence in the world’s most iconic and prestigious department stores, independent and online luxury fashion retailers.

For more information, visit www.zimmermann.com

Media contacts

Advent International
Graeme Wilson or Harry Cameron
Tel: +44 (0)20 7353 4200
Advent@teneo.com

Style Capital
info@stylecapital.it
+39 02 45499848

ZIMMERMANN
Australia
Marie Claude Mallat
MCMPR
+61 418 206 920
mc@mcmpr.com.au

EU/USA
Malcolm Carfrae
Carfrae Consulting
+1 917 239 5191
malcolm@carfraeconsulting.com

Campbell to acquire Sovos Brands, leader in high-Growth premium Italian sauces

Powerful combination expected to fuel earnings growth; Aligns with and advances Campbell’s focused strategic plan

  • Strengthens and diversifies Campbell’s portfolio by enhancing Meals & Beverages division with additional growth-oriented
    brands, including premium market-leading Rao’s to complement core, mainstream portfolio and provide runway for adjacent category expansion
  • Overdelivers stated strategic goal of building a $1 billion sauces business by entering the ultra-distinctive pasta sauce
    market
  • Creates significant shareholder value through meaningful sales growth, EBIT acceleration, and cost synergies
  • Expected to be accretive to adjusted diluted earnings per share by the second year
  • Transaction conference call today at 8:00 a.m. EST

August 7, 2023: CAMDEN, N.J. & LOUISVILLE, Colo.–(BUSINESS WIRE)–Campbell Soup Company (NYSE: CPB) and Sovos Brands, Inc. (Nasdaq: SOVO) today announced that the companies have entered into an agreement for Campbell to acquire Sovos Brands, Inc. for $23 per share in cash, representing a total enterprise value of approximately $2.7 billion. This represents a 14.6x adjusted EBITDA multiple1 including expected annual run rate synergies of approximately $50 million. The strategic transaction adds a high-growth, market-leading premium portfolio of brands to diversify and enhance Campbell’s Meals & Beverages division, providing a substantial runway for sustained profitable growth.

Sovos Brands had annual adjusted net sales of $8372 million in calendar year 2022 and is a compelling growth story as a North America focused food company with compounded annual organic net sales growth rate of 28%3 from fiscal 2019 to fiscal 2022 offering a variety of premium products including pasta sauces, dry pasta, soups, frozen entrées, frozen pizza and yogurts under the brand names Rao’s , Michael Angelo’s and noosa. The flagship Rao’s brand, which represented approximately 69%4 of Sovos Brands adjusted net sales in fiscal 2022, grew organic net sales by 34.9%5 compared to the prior year.

“We’re thrilled to add the most compelling growth story in the food industry and welcome the talented employees who have built a nearly $1 billion portfolio,” said Campbell’s President and CEO Mark Clouse. “This acquisition fits perfectly with and accelerates our strategy of focusing on one geography, two divisions and select key categories that we know well. Our focused strategy has enabled us to deliver strong results over the last five years, enhance our brands and capabilities, and generate strong cash flow to lower debt. With all this progress, I am confident in our readiness to execute and integrate this important acquisition. The Sovos Brands portfolio strengthens and diversifies our Meals & Beverages division and paired with our faster-growing and differentiated Snacks division, makes Campbell one of the most dependable, growth-oriented names in food.”

“Today marks a momentous occasion for Sovos Brands as we announce our plans to join the Campbell’s family,” commented Todd Lachman, Founder, President and Chief Executive Officer of Sovos Brands, Inc. “We have built a one-of-a-kind, high growth food company focused on taste-led products across a portfolio of premium brands, anchored by the Rao’s brand. Our success would not have been possible without the incredibly talented and passionate team at Sovos Brands, which has been instrumental in building one of the fastest growing food companies of scale in the industry today. This transaction is expected to create substantial value for our shareholders, resulting in a 92% increase from our 2021 IPO price. As one of the most trusted and respected food companies in North America, I’m confident in Campbell’s ability to continue bringing our products to more households and further building on our track record of growth and success for years to come.”

Compelling Strategic Rationale

Multi-dimensional Value Creation

  • Acquisition unlocks significant value through strong and sustainable growth opportunities
  • Expect a fast, effective and efficient integration and synergy unlock given familiarity with categories and Campbell’s strong capabilities, processes and proven integration playbook
  • The acquisition is expected to provide considerable earnings growth contribution to the division while unlocking
    additional value through meaningful cost synergies
  • Campbell’s supply chain excellence and scale are expected to drive operating synergies for Sovos Brands, while
    improving scale efficiency of Campbell’s core operations

Attractive Sustainable Profitable Growth

  • Significant whitespace opportunity for Rao’s and Michael Angelo’s through increased distribution, growing items per store and household penetration to category peer levels
  • Campbell’s expertise in retail execution is expected to enhance shelf productivity, geographic footprint, and
    sub-category penetration
  • Sovos Brands’ expertise in innovation, category expansion and the marketing of high-growth brands is expected to enhance and strengthen Campbell’s capabilities as the portfolio continues to transform

Accelerates Campbell’s Focused, Strategic Plan

  • Further advances the company’s focused one geography, two division roadmap – Meals & Beverages and Snacks
  • Solidifies role of Meals & Beverages as a sustainable and dependable contributor to the enterprise, by
    complementing a stable, core portfolio in mainstream product categories with a fast-growing differentiated, premium
    segment
  • Delivers Campbell’s $1 billion sauces strategic objective by filling in critical white space in the growing ultradistinctive Italian sauce category, a segment where Campbell’s does not currently compete
  • Extends Campbell’s presence into the fast growing, on-trend, premium frozen meals segment with Rao’s and
    Michael Angelo’s , while adding meaningful scale to the existing Pepperidge Farm’s frozen portfolio


Financial Highlights

The all-cash offer for Sovos Brands of $23 per share for a total enterprise value of approximately $2.7 billion represents an adjusted EBITDA multiple of 14.6x including run rate synergies and 19.8x excluding synergies6. The acquisition is expected to support Campbell’s long-term financial growth algorithm with expected annualized cost synergies reaching approximately $50 million over the next two years, applying the learnings from the successful integrations of Snyder’s-Lance and Pacific Foods. The transaction is expected to be accretive to adjusted diluted earnings per share by the second year, excluding one-time integration expenses and costs to achieve synergies.

Following the completion of the transaction, Sovos Brands’ results will be managed within Campbell’s Meals & Beverage division.

Transaction Structure and Timing
Campbell plans to finance the acquisition price through the issuance of new debt. Projected leverage is expected to be approximately 4x7 at closing. Given Campbell’s expectation of continued strong cash flow from operations, the company remains committed to maintaining its capital allocation priorities that include continued investment in key growth and productivity initiatives in the business, maintaining a competitive dividend, a focus on reaching our target leverage ratio of approximately 3x by the end of the third year, and continuing anti-dilutive share repurchases.

The closing of the transaction is subject to Sovos Brands stockholder approval and customary closing conditions, including regulatory approvals. Closing is expected by the end of December 2023. The transaction has been approved by both Boards of Directors. In addition, each member of the Board of Directors of Sovos Brands that is a stockholder of Sovos Brands and certain funds affiliated with Advent International that are stockholders of Sovos Brands have entered into voting agreements with Campbell, pursuant to which each has agreed, among other things, to support the transaction.

Evercore acted as Campbell’s lead financial advisor in this transaction. Davis Polk & Wardwell LLP acted as Campbell’s legal counsel. Goldman Sachs & Co. LLC and Centerview Partners LLC acted as financial advisors to Sovos Brands, and Hogan Lovells US LLP and Richards, Layton & Finger, P.A. acted as legal counsel. Weil, Gotshal & Manges LLP acted as Advent International’s legal counsel.

Transaction Conference Call and Webcast
Campbell’s management team will host a conference call to discuss the acquisition announcement today at 8:00 a.m. EST. Participants calling from the U.S. may dial in using the toll-free phone number (888) 210-3346. Participants calling from outside the U.S. may dial in using phone number (646) 960-0253. The conference access code is 2518868. Additionally, access to a live listen-only audio webcast is available at the following link: https://events.q4inc.com/attendee/701780401. The accompanying slide presentation, as well as a replay of the webcast, will be available at investor.campbellsoupcompany.com/events-and-presentations.

About Campbell
For more than 150 years, Campbell (NYSE: CPB) has been connecting people through food they love. Generations of consumers have trusted Campbell to provide delicious and affordable food and beverages. Headquartered in Camden, N.J. since 1869, Campbell generated fiscal 2022 net sales of $8.6 billion. Our portfolio includes iconic brands such as Campbell’s, Cape Cod, Goldfish, Kettle Brand, Lance , Late July, Milano, Pace, Pacific Foods, Pepperidge Farm, Prego, Snyder’s of Hanover, Swanson and V8. Campbell has a heritage of giving back and acting as a good steward of the environment. The company is a member of the Standard & Poor’s 500 as well as the FTSE4Good and Bloomberg Gender-Equality Indices. For more information, visit www.campbellsoupcompany.com or follow company news on Twitter via @CampbellSoupCo.

About Sovos Brands, Inc.
Sovos Brands, Inc. is a consumer-packaged food company focused on acquiring and building disruptive growth brands that bring today’s consumers great tasting food that fits the way they live. The company’s product offerings include a variety of pasta sauces, dry pasta, soups, frozen entrées, frozen pizza and yogurts, all of which are sold in North America under the brand names Rao’s, Michael Angelo’s and noosa. All Sovos Brands’ products are built with authenticity at their core, providing consumers with one-of-a-kind food experiences that are genuine, delicious, and unforgettable. The company is headquartered in Louisville, Colorado. For more information on Sovos Brands and its products, please visit www.sovosbrands.com.

Additional Information For Sovos Brands, Inc. Shareholders and Where to Find It
This press release does not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities or a solicitation of any vote or approval. This press release relates to a proposed acquisition of Sovos Brands, Inc. (”Sovos Brands”) by Campbell Soup Company (“Campbell”). In connection with this transaction, Sovos Brands will file relevant materials with the Securities and Exchange Commission (the “SEC”). INVESTORS AND SECURITY HOLDERS OF SOVOS BRANDS ARE URGED TO READ THE PROXY STATEMENT AND OTHER DOCUMENTS THAT MAY BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Any definitive proxy statement(s) (when available) will be mailed to stockholders of Sovos Brands. Investors and security holders will be able to obtain free copies of these documents (when available) and other documents filed with the SEC by Sovos Brands through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Sovos Brands will be available free of charge on the Sovos Brands’ website at https://sovosbrands.com or by contacting Sovos Brands by email at IR@sovosbrands.com or by mail at 168 Centennial Parkway, Suite 200, Louisville, CO 80027.

Participants in the Solicitation
Sovos Brands, its directors and certain of its executive officers may be considered participants in the solicitation of proxies from the Sovos Brands’stockholders in connection with the proposed transaction. Information about the directors and executive officers of Sovos Brands is set forth in its Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on March 8, 2023, its Proxy Statement for its 2023 Annual Meeting of Stockholders, which was filed with the SEC on April 27, 2023, its Quarterly Report on Form 10-Q for the quarter ended April 1, 2023, which was filed with the SEC on May 10, 2023, and in other documents filed with the SEC by Sovos Brands and its officers and directors.

These documents can be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials in connection with the transaction to be filed with the SEC when they become available.

Forward-Looking Statements
Certain statements in this press release regarding the proposed transaction, including any statements regarding the expected timetable for completing the proposed transaction, benefits of the proposed transaction, future opportunities, future financial performance and any other statements regarding future expectations, beliefs, plans, objectives, financial conditions, assumptions or future events or performance that are not historical facts are “forward-looking” statements made within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “aim,” “anticipate,” “believe,” “could,” “ensure,” “estimate,” “expect,” “forecasts,” “if,” “intend,” “likely” “may,” “might,” “outlook,” “plan,” “positioned,” “potential,” “predict,” “probable,” “project,” “should,” “strategy,” “target,” “will,” “would,” and similar expressions, and the negative thereof, are intended to identify forward-looking statements.

All forward-looking information is subject to numerous risks and uncertainties, many of which are beyond the control of Sovos Brands or Campbell, that could cause actual results to:

    • the conditions to the completion of the Sovos Brands transaction, including obtaining Sovos Brands stockholder approval, may not be satisfied, or the regulatory approvals required for the transaction may not be obtained on the terms expected, on the anticipated schedule, or at all;
    • long-term financing for the Sovos Brands transaction may not be obtained by Campbell on favorable terms, or at all;
    • closing of the Sovos Brands transaction may not occur or be delayed, either as a result of litigation related to the transaction or otherwise or result in significant costs of defense, indemnification and liability;
    • the risk that the cost savings and any other synergies from the Sovos Brands transaction may not be fully realized by Campbell or may take longer or cost more to be realized than expected, including that the Sovos Brands transaction may not be accretive to Campbell within the expected timeframe or the extent anticipated
    • completing the Sovos Brands transaction may distract Campbell’s management from other important matters;
    • the risks related to the availability of, and cost inflation in, supply chain inputs, including labor, raw materials, commodities, packaging and transportation;
    • Campbell’s ability to execute on and realize the expected benefits from its strategy, including growing sales in snacks and growing/maintaining its market share position in soup;
    • the impact of strong competitive responses to Campbell’s efforts to leverage its brand power with product innovation, promotional programs and new advertising; the risks associated with trade and consumer acceptance of product improvements, shelving initiatives, new products and pricing and promotional strategies;
    • the ability to realize projected cost savings and benefits from cost savings initiatives and the integration of recent acquisitions;
    • disruptions in or inefficiencies to Campbell’s or Sovos Brands’ supply chain and/or operations, including reliance on key supplier relationships;
    • the impacts of, and associated responses to, the COVID-19 pandemic on Campbell’s and/or Sovos Brands’ business, suppliers, customers, consumers and employees;
    • the risks related to the effectiveness of Campbell’s hedging activities and Campbell’s ability to respond to volatility in commodity prices;
    • Campbell’s ability to manage changes to its organizational structure and/or business processes, including selling, distribution, manufacturing and information management systems or processes; changes in consumer demand for Campbell’s and Sovos Brands’ products and favorable perception of such brands;
    • changing inventory management practices by certain of Campbell’s and Sovos Brands’ key customers;
    • a changing customer landscape, with value and e-commerce retailers expanding their market presence, while certain of the Campbell’s key customers maintain significance to Campbell’s business; product quality and safety issues, including recalls and product liabilities;
    • the possible disruption to the independent contractor distribution models used by certain of Campbell’s businesses, including as a result of litigation or regulatory actions affecting their independent contractor classification;
    • the uncertainties of litigation and regulatory actions against Campbell’s or Sovos Brands;
    • the costs, disruption and diversion of management’s attention associated with activist investors;
    • a disruption, failure or security breach of Campbell’s, Campbell’s vendors’, Sovos Brands’ or Sovos Brands’ vendors information technology systems, including ransomware attacks;
    • impairment to goodwill or other intangible assets;
    • Campbell’s and Sovos Brands’ ability to protect their respective intellectual property rights;
    • increased liabilities and costs related to Campbell’s defined benefit pension plans;
    • Campbell’s and Sovos Brands’ ability to attract and retain key talent;
    • goals and initiatives related to, and the impacts of, climate change, including weather-related events;
    • negative changes and volatility in financial and credit markets, deteriorating economic conditions and other external factors, including changes in laws and regulations; and unforeseen business disruptions or other impacts due to political instability, civil disobedience, terrorism, armed hostilities (including the ongoing conflict between Russia and Ukraine), extreme weather conditions, natural disasters, other pandemics or other calamities

Additional information concerning these and other risk factors can be found in Campbell’s and Sovos Brands filings with the SEC and available through the SEC’s Electronic Data Gathering and Analysis Retrieval system at http://www.sec.gov, including Campbell’s and Sovos Brands’ most recent Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

The discussion of uncertainties is by no means exhaustive but is designed to highlight important factors that may impact the outlook of Campbell and Sovos Brands. Campbell and Sovos Brands each disclaim any obligation or intent to update the forward-looking statements in order to reflect events or circumstances after the date of this release except as required by law.

Non-GAAP Financial Measures
This press release includes measures that are not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Campbell uses Sovos Brands Adjusted EBITDA and organic net sales, which are non-GAAP measures, in this press release. For each of these non-GAAP financial measures, we have included below a reconciliation of the differences between the non-GAAP measure and the most comparable GAAP measure. These non-GAAP measures should be viewed in addition to, and not in lieu of, the comparable GAAP measure.



(1) Reflects Net Sales for the Birch Benders brand generated in the 53 weeks ended December 31, 2022.
(2) Reflects Net Sales generated in the 53rd week by the Rao’s , Michael Angelo’s and noosa brands.
(3) Sovos Brands Organic Net Sales and Organic Net Sales growth are defined as Reported Net Sales or Reported Net Sales growth excluding, when they occur, the impact of a 53rd week of shipments, acquisitions, and divestitures.

Campbell discusses projected leverage in this press release only in relation to management’s expectations of the future effect of the Sovos Brands transaction and has not provided a reconciliation of these forward-looking projected leverage expectations to the mostly directly comparable GAAP measure due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, including adjustments
that could be made for actuarial gains or losses on pension and postretirement plans because these impacts are dependent on future changes in market conditions, transaction and integration costs and other charges reflected in Campbell’s reconciliations of historical numbers, the amounts of which, based on historical experience, could be significant.

Media contacts

Campbell Soup Company, Inc.
Investors
Rebecca_gardy@campbells.com
Media
James_Regan@campbells.com

Sovos Brands, Inc.
Investors
Joshua Levine
IR@sovosbrands.com
Media
Lauren Armstrong
media@sovosbrands.com

Advent International to enter a partnership with the founder of the Parfums de Marly and INITIO Parfums Privés niche fragrance brands to accelerate global growth

Paris, 22 June 2023 – Advent International (“Advent”), one of the world’s largest and most experienced private equity investors, today announces that it has reached an agreement to enter into a partnership with Julien Sprecher, the founder of the group behind Parfums de Marly and INITIO Parfums Privés (together the “Group”), whereby Advent will invest in the Group to support the global growth of the brands.

Parfums de Marly was founded by Julien Sprecher, inspired by his passion for the splendour of 18th century France, an era which is widely regarded as the golden age of perfumery. The brand encapsulates the temporal duality of heritage and modernity, with a focus on authentic and quality perfumery that honours French perfumery savoir-faire.

INITIO masters the power of scent through singular and functional fragrances that trigger an emotional and physiological response. A new perfume dimension to access another dimension of the being.

The Group has grown rapidly to become a leading niche perfumery house in the attractive niche luxury fragrance segment, which represents the fastest-growth area within the sizeable ~$60bn global fragrance market, and benefits from high levels of customer loyalty and resilience. The Group is truly global with a strong presence in the US, Europe and the Middle-East.

Advent will acquire a majority shareholding in the Group from Julien Sprecher, who will remain with the Group as Executive Chairman, Creative Director and as a large minority shareholder.

Advent will leverage its considerable experience within the consumer and beauty sector – which includes investments in Douglas (specialist retailer of premium beauty products, including perfumes), Dufry (global travel retailer), Orveon (owner of the bareMinerals, BUXOM, and Laura Mercier cosmetics brands), and Olaplex (global prestige and professional hair care brand) – to support the management team’s ambition to accelerate international growth and strengthen the Group’s omni-channel strategy.

Commenting on the announcement, Ranjan Sen, Managing Partner, Advent International, said: “We are delighted to have acquired a majority shareholding in Parfums de Marly and INITIO Parfums Privés – two iconic and distinctive brands with creative, exciting fragrances at their heart. Under Julien Sprecher’s visionary guidance, the Group has established itself as a leader in niche luxury fragrance, and we see a considerable opportunity to accelerate its growth and penetration in key global markets.”

Nicolas Chavanne, Managing Director, Advent International, commented: “As a global private equity firm with strong experience backing iconic consumer and beauty companies, we firmly believe that Advent is the right partner to support the next phase of the Group’s journey. These brands are emblematic of a new generation of exclusive and distinctive fragrance houses – combining sophistication with creative flair – that we are proud to support. We look forward to working with Julien and the Group’s leadership team to further scale the business and achieve its full potential.”

Julien Sprecher, Executive Chairman, Parfums de Marly Group, added: “Partnering with Advent is a fantastic opportunity for the Group. Since our initial discussions, I have been deeply impressed with Advent’s forward-thinking approach and especially with their desire to support the growth ambitions of the business, while protecting the DNA of the brands, and maintaining continuity with the existing team and its existing partnerships with suppliers and distributors.”

Julien Sausset, Group CEO, remarked: “We are convinced that Advent is the ideal partner to help us to take our brands to the next level. Beyond clear alignment in our strategic vision for the business, we established a strong relationship with Advent from day one and have been deeply impressed by the quality of their team.”

ABOUT ADVENT INTERNATIONAL

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of December 31, 2022, had €86 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, please visit www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

ABOUT PARFUMS DE MARLY

Parfums de Marly was created in 2009 by Julien Sprecher, expressing his passion for the olfactory creation and the splendor of the 18th century, through a temporal duality that embodies the spirit of the brand: “A juxtaposition of the present and past as coexisting and unexpected sources of inspiration.”

ABOUT INITIO PARFUMS PRIVÉS

INITIO Parfums Privés was born in 2015, out of the desire to restore the greatness of perfume and initiate the power of scent through singular, emotional and functional fragrance.

Media contacts

Graeme Wilson or Harry Cameron
Tel: +44 (0)20 7353 4200
Advent@teneo.com

Ms. Laetitia Émile-Zola
Tel: +33 6 10 14 65 00
laetitia.emilezola@lncparfums.com

Advent International agrees to partial sale of InPost shareholding to PPF Group

London, 26 May 2023 – Advent International (“Advent”), one of the world’s largest and most experienced private equity investors, has agreed to sell part of its shareholding in InPost Group (“InPost” or “the Group”), representing 15% of the Group’s total share capital, for €10 per share to PPF Group (“PPF”), a privately-held international investment company.

Listed on Euronext Amsterdam, InPost is the leading European automated parcel machine (“APM”) service provider. Under the terms of the agreement, Advent will sell the 15% shareholding, with the option for PPF to purchase a further 15% of the Group’s total share capital at an agreed price. Each of Advent and PPF has agreed to a lockup agreement on the remainder of its holding in InPost for a 6 month period (subject to certain customary exceptions with each party being permitted to sell shares equivalent to up to 2.0% of InPost’s share capital during the lock-up period).

On completion of the initial sale, Advent will remain the largest shareholder in the Group with a 30.3% ownership stake.

Since its initial investment in 2017, Advent has invested substantially in InPost to support the management team and facilitate market share expansion across Europe. Since then, the Group has grown to become the leading out-of-home e-commerce delivery company in Europe, providing delivery services through its network of more than 29,000 APMs and operating across 9 European countries. InPost successfully listed on Euronext Amsterdam in January 2021, and was at that time the largest ever tech IPO in Europe. Since then, revenues and EBITDA have more than doubled as the business continues its industry leading expansion.

Investment from PPF marks an important strategic milestone for Advent and InPost, adding further expertise and investment that will support InPost’s continued growth.

Nick Rose, InPost Board member and Managing Director at Advent International, said, “InPost has grown to become Europe’s leading out-of-home e-commerce delivery company, led by a fantastic management team which has put the customer at the heart of their business. During our 6 year partnership with founder Rafal Brzoska, the Company has grown earnings more than fifty fold. That growth momentum continues today and therefore we’re exceptionally pleased to now have PPF, with its strong investment experience, alongside us on the share register.”

Ranjan Sen, InPost Board member and Managing Partner at Advent International, said, “PPF has a strong track record of value creation, across a wide range of sectors in Europe, and we’re delighted that they recognise the quality and future growth opportunities for the business. We are confident that by leveraging our collective expertise we can continue to unlock InPost’s full potential. Our ongoing support highlights the confidence we have in this exciting new chapter for the business.”

Didier Stoessel, Chief Investment Officer of PPF Group, said, “We are pleased to become a shareholder in InPost, a company with significant scope to expand and build upon its market leading position. As an experienced investor in e-commerce and a wide range of other sectors globally, PPF is well placed to help InPost grow its business internationally.”

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has made over 405 investments across 42 countries, and as of December 31, 2022, had €86 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, please visit www.adventinternational.com

About PPF

PPF Group operates in 25 countries, investing in multiple sectors, including financial services, telecommunications, media, e-commerce, and other sectors, including real estate, biotechnology and transportation. PPF Group’s reach spans from Europe to North America and across Asia. The Group owns assets to the value of EUR 40.13 billion and employs 70,000 people globally (30 June 2022).

For more information, please visit www.ppf.eu/en

About InPost S.A.

InPost S.A. InPost (Euronext Amsterdam: INPST) has revolutionized e-commerce parcel delivery in Poland and is now one of the leading out-of-home e-commerce enablement platform in Europe. Founded in 1999 by Rafał Brzoska in Poland, InPost provides delivery services through our network of more than 29,000 Automated Parcel Machines (“APMs”) in 9 countries across Europe, as well as to-door courier and fulfilment services to ecommerce merchants. InPost’s Paczkomat® machines provide consumers with a cheaper, flexible, convenient, environmentally friendly, and contactless delivery option.

For more information, please visit www.inpost.eu

Media contacts

Graeme Wilson or Harry Cameron
Tel: +44 (0)20 7353 4200
Advent@teneo.com

Baxter signs definitive agreement to divest its BioPharma Solutions business to Advent International and Warburg Pincus for $4.25 billion

Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation

Net proceeds planned to be redeployed for debt repayment in accordance with Baxter’s stated capital allocation priorities

Establishes a diversified, standalone contract development and manufacturing organization (CDMO) platform enhancing healthcare worldwide

Deerfield, Ill., Boston, Mass., and New York, N.Y. – May 8, 2023 – Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

Under the terms of the definitive agreement, Baxter will receive $4.25 billion in cash, subject to certain closing adjustments, with net after-tax proceeds currently estimated to be approximately $3.4 billion. The transaction is expected to close in the second half of 2023, subject to receipt of customary regulatory approvals and satisfaction of other customary closing conditions. Baxter intends to utilize the after-tax proceeds to reduce its debt, consistent with the company’s stated capital allocation priorities. For the full fourth quarter 2023, Baxter estimates the transaction to result in dilution of approximately $0.10 per share to the company’s earnings, the total amount depending on the time of close. This amount is expected to be partially offset through reduced interest expense payments following anticipated debt repayment.

“Today represents an important step in Baxter’s ongoing transformation journey as we continue to execute against our strategic priorities, enhance our focus and create additional value for all our stakeholders,” said José (Joe) E. Almeida, Chairman, President and Chief Executive Officer at Baxter. “BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. Advent International and Warburg Pincus have extensive experience helping innovative healthcare companies advance their mission and strategic priorities. I am confident that under their stewardship, BPS will continue to build on its leadership position, foster world-class talent, invest in new capabilities and capacity, and provide leading-edge, high-quality solutions for its clients.”

BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades. As a standalone company and in partnership with Advent and Warburg Pincus, BPS will operate as a premier, independent end-to-end CDMO providing a range of services for clients, from clinical research to commercial deployment. BPS should be well-positioned to accelerate its go-to-market strategy and clinical development pipeline, execute on throughput expansion and drive further product innovation. The proposed transaction includes BPS manufacturing facilities and approximately 1,700 employees in Bloomington, Indiana and Halle, Germany. BPS is expected to generate revenues of approximately $600 million on a reported basis for full year 2023.

“BPS is a premier asset at the forefront of the biopharma industry, and one we’ve been closely following for a number of years,” said John Maldonado, a Managing Partner at Advent. “Leveraging our deep sector expertise and significant strategic resources, we believe this partnership can unlock multiple opportunities for growth and help the business realize its full potential by serving blue-chip customers, including Baxter, with high-value, specialized and end-to-end capabilities as a standalone company. We’re thrilled to partner with BPS to alleviate critical pain points for its customers and to help them provide life-changing therapies to patients around the world.”

“BPS’s success and exceptional market reputation within the pharmaceutical sector position the company well to continue to grow its mission-critical services across a variety of therapeutic areas including oncology, metabolic disease, and infectious disease, among others,” said TJ Carella, Managing Director and Head of Healthcare at Warburg Pincus. “We are excited to partner with Advent and the impressive team at BPS who have developed differentiated technical capabilities and established an industry-leading reputation for quality and reliability in the supply chain for parenteral drugs.”

“We strongly believe in the company’s mission to partner with pharmaceutical companies around the world to provide the scientific expertise, sterile solutions, and customized support needed to meet the unique challenges of today’s healthcare environment and are eager to carry forward the strong franchise and legacy that Baxter has built at BPS,” added Ruoxi Chen, Managing Director at Warburg Pincus. “This investment underscores our commitment to working with companies that support the delivery of innovative life sciences products and services worldwide.”

“BPS has an exceptional track record of delivering high-quality services and products addressing the unique needs of pharmaceutical and biotech customers worldwide,” said Carmine Petrone, a Managing Director on Advent’s Healthcare team. “We believe that, alongside our partners at Warburg Pincus, our collective carve out experience, vision and support will help create a scaled, diversified platform poised to capitalize on its significant market opportunity. We look forward to supporting BPS’s continued growth as it enhances its positive impact on patients worldwide and continues to help its customers achieve their commercialization objectives.”

For over 30 years, Advent has been investing in the healthcare sector. The firm has completed over 50 investments in 17 countries worldwide across a range of sub-sectors, including pharmaceuticals, life sciences and medical devices. Advent’s notable recent healthcare investments include Iodine Software and RxBenefits, and the firm’s recent notable global pharmaceutical services investments include BioDuro, GS Capsule, ICE Group, Suven Pharmaceuticals/Cohance Lifesciences, and Syneos Health.

Since inception, Warburg Pincus has invested over $16 billion in more than 180 healthcare companies, including Summit Health, Modernizing Medicine, Ensemble Healthcare Partners, and Global Healthcare Exchange, and has been an active investor in life sciences, with notable investments in Polyplus, Norstella, Sotera Health, and Bausch + Lomb, among others.

Perella Weinberg Partners is serving as financial advisor and Sullivan & Cromwell is serving as legal advisor to Baxter. Moelis & Company LLC and Truist Securities are serving as financial advisors and Cleary Gottlieb Steen & Hamilton and Ropes & Gray are serving as legal advisors to Advent and Warburg Pincus.

Forward-Looking Statements
This press release contains forward-looking statements related to the proposed transaction between Baxter International Inc., Advent International Inc. and Warburg Pincus LLC, including Baxter’s estimated after-tax proceeds from the proposed transaction and its estimated dilution to earnings per share for the full fourth quarter of 2023, the expected timeframe for completing the proposed transaction, strategic and other potential benefits of the potential transaction, and other statements about future beliefs, goals, plans or prospects. These forward-looking statements are subject to risks and uncertainties that include, among other things, risks related to the receipt of customary regulatory approvals and the satisfaction of other customary closing conditions in the anticipated timeframe or at all, including the possibility that the proposed transaction does not close; risks related to the ability to realize the anticipated strategic, financial or other benefits of the proposed transaction, and other risks identified in Baxter’s most recent filings on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter’s website. Actual results could differ materially from anticipated results. Baxter does not undertake to update its forward-looking statements or any of the statements contained in this press release.

About Baxter

Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of December 31, 2022, had $92 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology.

For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

About Warburg Pincus

Warburg Pincus LLC is a leading global growth investor. The firm has more than $80 billion in assets under management. The firm’s active portfolio of more than 250 companies is highly diversified by stage, sector, and geography. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Founded in 1966, Warburg Pincus has raised 21 private equity and 2 real estate funds, which have invested more than $109 billion in over 1,000 companies in more than 40 countries. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, São Paulo, Shanghai, and Singapore.

For more information, please visit www.warburgpincus.com. Follow us on LinkedIn.

Media contacts

Baxter
Andrea Johnson, (224) 948-5353
media@baxter.com

Advent International
Zachary Tramonti / Anna Epstein / Kevin Siegel
FGS Global
AdventInternational-US@FGSGlobal.com

Warburg Pincus
Kerrie Cohen, (917) 887-9184
Kerrie.cohen@warburgpincus.com

U.S. private equity firm Advent International and BCI complete acquisition of Maxar Technologies

Maxar becomes privately held company

WESTMINSTER, Colo., BOSTON & NEW YORK, May 3, 2023 — Maxar Technologies (“Maxar” or the “Company”), provider of comprehensive space solutions and secure, precise, geospatial intelligence, today announced that U.S. private equity firm Advent International (“Advent”), alongside minority investor British Columbia Investment Management Corporation (“BCI”), completed their acquisition of Maxar. With the closing of the transaction, Maxar will remain a U.S.-controlled, owned and operated company.

On December 16, 2022, Advent and Maxar announced that they had entered into a definitive merger agreement under which all outstanding shares of Maxar common stock would be acquired for $53.00 per share in cash, valuing Maxar at approximately $6.4 billion.

With the completion of the transaction, Maxar’s common stock has ceased trading and is no longer listed on the New York Stock Exchange, and Maxar’s common stock will also be de-listed from the Toronto Stock Exchange. An application will be made for Maxar to cease to be a reporting issuer in the applicable Canadian jurisdictions as a result of completion of the transaction.

Advisors
J.P. Morgan Securities LLC served as financial advisor to Maxar and Wachtell, Lipton, Rosen & Katz served as lead counsel to Maxar. Milbank LLP served as Maxar’s legal advisor with respect to certain space industry and regulatory matters.

Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC served as financial advisors to Advent and Weil, Gotshal & Manges LLP served as lead counsel to Advent. Covington & Burling LLP served as Advent’s legal advisor with respect to certain regulatory matters.

Skadden, Arps, Slate, Meagher & Flom LLP served as lead counsel to BCI. Freshfields Bruckhaus Deringer LLP served as BCI’s legal advisor with respect to certain regulatory matters.

Forward-Looking Statements
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements concerning general economic conditions, our financial condition, including our anticipated revenues, earnings, cash flows or other aspects of our operations or operating results, and our expectations or beliefs concerning future events; and any statements using words such as “believe,” “expect,” “anticipate,” “plan,” “intend,” “foresee,” “should,” “would,” “could,” “may,” “estimate,” “outlook” or similar expressions, including the negative thereof, are forward-looking statements that involve certain factors, risks and uncertainties that could cause Maxar’s actual results to differ materially from those anticipated.

About Maxar

Maxar Technologies is a provider of comprehensive space solutions and secure, precise, geospatial intelligence. We deliver disruptive value to government and commercial customers to help them monitor, understand and navigate our changing planet; deliver global broadband communications; and explore and advance the use of space. Our unique approach combines decades of deep mission understanding and a proven commercial and defense foundation to deploy solutions and deliver insights with unrivaled speed, scale and cost effectiveness. Maxar’s 4,400 team members in over 20 global locations are inspired to harness the potential of space to help our customers create a better world. For more information, visit www.maxar.com.

About Advent International

Founded in 1984 and headquartered in Boston, MA, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of December 31, 2022, had $92 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. This includes investments in defense, security and cybersecurity as well as critical national infrastructure.

For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit

Website: www.adventinternational.com

LinkedIn: www.linkedin.com/company/advent-international

About BCI

British Columbia Investment Management Corporation (BCI) is amongst the largest institutional investors in Canada with C$211.1 billion under management, as of March 31, 2022. Based in Victoria, British Columbia, with offices in New York City and Vancouver, BCI is invested in: fixed income and private debt; public and private equity; infrastructure and renewable resources; as well as real estate equity and real estate debt. With our global outlook, we seek investment opportunities that convert savings into productive capital that will meet our clients’ risk and return requirements over time.

BCI’s private equity program actively manages a C$24.8 billion global portfolio of privately-held companies and funds with the potential for long-term growth and value creation. Leveraging our sector-focused teams in business services, consumer, financial services, healthcare, industrials, and technology, media and telecommunications, we work with strategic private equity partners to source and manage direct and co-sponsor/co-investment opportunities.

For more information, please visit bci.ca.

LinkedIn: https://www.linkedin.com/company/british-columbia-investment-management-corporation-bci/

Media contacts

For Maxar:
Investor Relations
Jonny Bell
(303) 684-5543
jonny.bell@maxar.com

Media Relations
Fernando Vivanco
(720) 877-5220
fernando.vivanco@maxar.com

OR

Scott Bisang / Eric Brielmann / Jack Kelleher
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449
dgi-jf@joelefrank.com

For Advent:
Bryan Locke / Jeremy Pelofsky
FGS Global
(212) 687-8080
adventinternational-us@fgsglobal.com

For BCI:
Olga Petrycki
Director, External Stakeholder Engagement
(778) 410-7310
media@bci.ca

Sunley House Changes Name to Advent Global Opportunities

New name better reflects integration and partnership with Advent International

Reinforces the importance of Advent Global Opportunities to the firm’s growth strategy

BOSTON, April 26, 2023 – Advent International (“Advent” or the “firm”), one of the largest and most experienced global private equity investors, today announced that Sunley House, the firm’s global investment platform focused on public and select private opportunities, has changed its name to Advent Global Opportunities, better reflecting the platform’s integration and partnership with Advent.

Launched in 2015, Advent Global Opportunities manages a concentrated portfolio of high-quality, high-conviction positions in public and select private companies. It will continue to pursue this strategy, collaborating with Advent’s private equity team and leveraging the resources of the firm and its network to identify and diligence attractive investment opportunities. The team is comprised of more than a dozen dedicated investment and business development professionals and is supported by Advent’s nearly 300 private equity professionals.

“Advent Global Opportunities has been an integral part of the firm for over eight years, and this name change reflects the depth of the team’s integration within Advent and our view of this platform as a key pillar of our firm’s long-term growth strategy,” said David Mussafer, Chairman and Managing Partner of Advent. “We are excited for this new chapter for Advent Global Opportunities as we continue to support the team’s momentum and invest in its future success.”

“Today’s announcement further emphasizes who we are and how we have evolved since our inception, as well as the strong and beneficial connection we have with Advent,” said Mohammed Anjarwala, Co-founder and Managing Director of Advent Global Opportunities. “We take a private equity approach to public markets, and our access to Advent’s deep intellectual capital, resources and relationships around the world sets our strategy apart. We believe our flexible global mandate positions us to capture the most attractive opportunities in today’s dynamic environment, and we are thrilled to move forward embracing the Advent name.”

ABOUT ADVENT GLOBAL OPPORTUNITIES

Advent Global Opportunities is Advent International’s global investment platform focused on public and select private opportunities. It manages a concentrated portfolio of high-quality, high-conviction investments with a long-term mandate and is fully integrated with Advent, one of the largest and most experienced global private equity investors. As a part of Advent, Advent Global Opportunities has access to a highly differentiated global base of intellectual capital built over more than 35 years of investing that provides unique idea sourcing and diligence capabilities.

For more information, visit https://ago.adventinternational.com/.

ABOUT ADVENT INTERNATIONAL

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of December 31, 2022, had $92 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Media contacts

Zachary Tramonti / Anna Epstein / Kevin Siegel
FGS Global
Tel: +1 212 687 8080
Adventinternational-US@fgsglobal.com

Envalior enters the engineering materials market as a new global leader

Düsseldorf, April 3, 2023 – Envalior, a leading global engineering materials business, celebrates its official launch as a new company today. With a turnover of around EUR 4 billion, and a highly skilled, diverse global workforce of around 4,000 employees worldwide, Envalior ranks among the top engineering materials companies globally.

Envalior emerges from the combination of two highly complementary industry leaders in engineering materials – DSM Engineering Materials (DEM) and LANXESS High Performance Materials (HPM) – under the ownership of global private equity firm Advent International and specialty chemicals company LANXESS.

The new company builds on a 100-year track record of customer-focused innovation and a strong global footprint in Asia, Europe, and the US, and will offer its customers a unique portfolio of leading product brands and recycled and bio-based materials, combined with deep application and materials expertise. The company’s high-performance solutions enable the transformation of key industries, such as automotive and new mobility, electronics and electrical, and consumer goods sectors. The new corporate brand reflects a combination of characteristics that best summarizes Envalior’s ambition: EN (engaging, enterprising, engineering, environment) and VALIOR (value-driven and value-creating).

Calum MacLean, CEO of Envalior, said: “All of us on Envalior’s leadership team are very excited to build on the impressive legacies of these two great companies. The launch of Envalior is a proud moment for us and all our employees around the world, and I am deeply grateful to everyone whose contributions have enabled us to reach this exciting milestone. Our new company’s product portfolio includes some of the most recognizable product brands in our industry, and we are a leading supplier to a number of key industries. By combining two highly complementary businesses, we have created a true industry leader that will realize value and drive progress for our customers, our employees, our shareholders, and society as a whole.”

MacLean also underlined that the company will continue the focus on sustainable solutions first started at DEM and HPM: “Envalior will build on its strong track record of innovating at the forefront of changing market dynamics and evolving customer needs focusing on sustainability. We will be known for our highly collaborative and pioneering spirit. Moving forward, we will continue to drive carbon-efficient and circular technology within our industry to enable sustainable solutions across the value chain.”

Ronald Ayles, Managing Partner and Global Head of Chemicals at Advent International, said: “We are very excited to be supporting Envalior as it takes its place as a new industry leader. Envalior has great potential for sustainable, long-term growth in the specialty materials industry. We look forward to working with the leadership team of Envalior and its employees to cement its strong market position and achieve its growth ambitions through continued investment.”

Matthias Zachert, CEO of LANXESS AG, said: “With the joint venture, we are launching a global champion in high-performance polymers. The company has all it takes to actively shape future trends such as in new mobility and to benefit from its great growth potential. We look forward to accompanying and supporting Envalior on this journey.”

A trusted partner to the automotive sector, Envalior delivers materials for lightweight elements that replace metals, e.g. in structural parts, allowing for essential CO2 emissions savings. Envalior also paves the way for e-mobility as its materials are used in battery and charging systems, electronic control systems, power electronics and many other automotive applications. Envalior’s high-performance solutions are also broadly used in the Electrical & Electronics industry, such as in smartphone components and a variety of consumer goods. The company consists of three global divisions: Performance Materials, Specialty Materials, and Intermediates.

About Envalior

Envalior is a leading global engineering materials solution provider with about 4,000 employees worldwide. With a 100-year track record of customer-focused innovation, Envalior focuses its deep material and application expertise on sustainable high-performance solutions. The company supplies many of the world’s key markets including automotive and new mobility, electronics and electrical, and consumer goods. For more information visit www.envalior.com

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of December 31, 2022, had $93 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

Advent has invested in over 30 companies in the chemicals industry over recent years. Examples include Caldic, a globally leading specialty chemicals distributor, Röhm, one of the global market leaders in methacrylate chemicals, allnex, a global leader in resins for the paints and coatings industry, Oxea, a leading supplier of oxo alcohols and oxo derivatives, and VIAKEM, a leading manufacturer of fine chemicals.

Advent’s approach is to provide significant support to management teams by assisting with operating resources and expertise from its Portfolio Support Group and third-party Operating Partner program.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Media contacts

Thomas Möller
Kekst CNC
+49 162 406 5042
thomas.moeller@kekstcnc.com

Marisa Wagner
Kekst CNC
+49 1525 437 2777
marisa.wagner@kekstcnc.com

Advent International Appoints Biopharma Executive James Mullen as Operating Partner

Executive Chairman of Editas and former CEO of Patheon and Biogen to Bolster Advent’s Pharma Services Investment Platform Across Contract Manufacturing, Commercialization and Research

BOSTON, March 28, 2023 – Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced the appointment of seasoned biopharma executive James (“Jim”) Mullen as an Operating Partner. Mullen will play a key role in further building out Advent’s pharmaceutical and pharma services platform, working with the firm’s healthcare investment team and the management teams of its portfolio companies.

“Jim has been a renowned leader in the biopharma sector for over four decades,” said John Maldonado, Managing Partner at Advent. “His knowledge and expertise will enhance our ability to identify and partner with industry-leading pharmaceutical and pharma services companies across contract manufacturing, commercialization, and research that can create value for patients through cutting-edge technology. We look forward to collaborating with Jim to expand Advent’s portfolio in this compelling area of investment.”

Mullen is an industry veteran who brings more than 40 years of biopharma industry experience, including pharmaceutical and biotech manufacturing expertise. Mullen currently serves as the Executive Chairman of Editas Medicine, a leading genome editing company, where he previously served as the company’s President and CEO. While at Editas, Mullen has contributed to numerous innovative patient-focused technologies, and the U.S. Patent and Trademark Office (USPTO) provided protections to intellectual property concerning CRISPR/Cas9 and CRISPR/Cas12a which covers fundamental aspects of Editas Medicine’s gene editing.

Mullen served as the CEO and director of Patheon, a pharmaceutical and manufacturing organization serving the pharmaceutical and biotechnology sectors. Under Mullen’s leadership, Patheon grew dramatically by serving some of the largest biopharma customers and was acquired by Thermo Fischer for $7.2B in 2017. He was also previously the CEO of Biogen Inc., one of the world’s largest biotechnology companies specializing in the discovery and treatment of neurological diseases. Mullen earned an MBA from Villanova University and a Bachelor of Science in chemical engineering from Rensselaer Polytechnic Institute.

“Throughout my career, I’ve been dedicated to supporting the development of transformative therapies that improve the lives of patients,” said Mullen. “With the advancement of technologies in the pharmaceutical sector, there are numerous companies poised to make an impact with the right financial and operating support. Advent’s depth of investment and operating expertise across pharma services positions the firm to drive value with their companies and I’m excited to partner with the firm to pursue these meaningful opportunities.”

“Jim’s work at Editas and Thermo Fisher have put him at the forefront of the cell and gene therapy revolution,” said Carmine Petrone, Managing Director at Advent. “We are excited to partner with Jim as we continue to look for transformative companies that are enabling the development, manufacture and commercialization of these advanced therapies.”

ABOUT ADVENT INTERNATIONAL

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of September 30, 2022, had $89 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Media contacts

Zachary Tramonti / Anna Epstein
FGS Global
Tel: +1 212 687 8080
Adventinternational-US@fgsglobal.com

Advent International agrees to sell Tag, a leading global marketing production company, to dentsu

London, 7 March 2023 – Advent International (“Advent”), one of the world’s largest and most experienced private equity investors, has entered into an agreement to sell Tag, a leading global omnichannel marketing production company, to Dentsu Group Inc. (Tokyo: 4324; ISIN: JP3551520004), one of world’s largest global marketing and advertising agency networks.

In the past five years, Advent has invested more than €100 million in Tag, which has grown to become a leading global end-to-end, tech enabled marketing activation platform. Tag’s global footprint and offerings have expanded substantially, it has developed an end to end proprietary marketing execution platform called Digital Interact (Di) and acquired six strategic businesses, enhancing Tag’s CGI, e-commerce, content origination, and data analytics capabilities. Tag now has a truly global presence, with a world class diverse leadership team who oversee 2,800 employees in over 29 countries across EMEA, APAC and the Americas. Tag’s end-to-end platform provides digital, personalised marketing for many of the world’s leading brands.

James Brocklebank, Managing Partner at Advent International, said, “Since acquiring Tag in 2017, and following more than €100 million of investment, the business has been transformed to become a highly successful standalone entity that is now one of the world’s leading omnichannel digital marketing production companies.”

Chris Benson, Director at Advent International, said, “We have worked in partnership with Tag’s leadership team to build a world leader in marketing activation. Under Advent’s ownership, the company has grown significantly and continues to achieve double digit organic revenue growth. We are excited for Tag and dentsu to build on this success and we wish David Kassler and his team all the best as they start this next phase of their journey.”

David Kassler, Global CEO, Tag, said, “We can’t wait to start this next phase of our journey and couldn’t be happier to be joining the dentsu family. The market is moving incredibly fast towards integrated services – the combination of Tag’s global technology-enabled content production with dentsu’s broader marketing, technology and consulting skills will be tremendously additive for both sets of our wonderful clients.

Advent acquired Williams Lea Tag from Deutsche Post DHL Group in December 2017, before successfully separating Williams Lea and Tag into standalone businesses. Williams Lea, a high growth provider of tech-enabled business support services for a hybrid workforce, serving some of the world’s largest financial, legal and consulting firms, remains under Advent’s ownership.

Evercore, UBS, Weil, EY, and PWC acted as advisors to Advent.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 400 private equity investments across 41 countries, and as of September 30, 2022, had $89 billion in assets under management. With 14 offices in 12 countries, Advent has established a globally integrated team of over 285 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology.

For more information, please visit www.adventinternational.com and follow Advent on LinkedIn.

About Tag

Tag works with leading brands to transform their business and marketing capabilities to deliver content at speed and scale across channels, cultures, and regions. With intelligent, sustainable, and technology-driven solutions (including their own end to end proprietary marketing execution platform called Digital Interact) at the heart of everything it does, Tag enables brands to operate more efficiently and effectively to stand out, grow and waste less. The organization will become dentsu’s sixth network brand and will retain the Tag brand for the foreseeable future.

www.tagww.com

About dentsu

Dentsu is the network designed for what’s next, helping clients predict and plan for disruptive future opportunities and create new paths to growth in the sustainable economy. Taking a people-centered approach to business transformation, we use insights to connect brand, content, commerce and experience, underpinned by modern creativity. As part of Dentsu Group Inc. (Tokyo: 4324; ISIN: JP3551520004), we are headquartered in Tokyo, Japan and our 65,000-strong employee-base of dedicated professionals work across four regions (Japan, Americas, EMEA and APAC). Dentsu combines Japanese innovation with a diverse, global perspective to drive client growth and to shape society.

dentsu website:
www.dentsu.com

Dentsu Group Inc. website:
www.group.dentsu.com/en

Media contacts

Tulchan
Graeme Wilson or Harry Cameron
Advent@tulchangroup.com
+44 (0)20 7353 4200

© 2002-2024 Advent International, L.P. All rights reserved

LinkedIn Instagram youtube